Clindamycin and bacterial load reduction as prophylaxis for surgical site infection after below-knee flap and graft procedures: a trial protocol.

Phase 1

• Conditions: Skin Cancer; Surgical site infection; Skin - Dermatological conditions; Cancer - Non melanoma skin cancer; Cancer - Malignant melanoma

• Registration Number: ACTRN12624000076572
• Lead Sponsor: James Cook University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-01-30
• Last Update Posted: 27 February 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 155

Inclusion Criteria

Patients presenting to recruiting skin cancer clinics for surgical management of skin cancer below the knee which requires a complex surgical technique (flap or graft repair).

Exclusion Criteria

Allergy to clindamycin, chlorhexidine or mupirocin; existing skin infection; unable to provide informed consent; peripheral vascular disease; diabetes; current use of antibiotics; clinical indication for antibiotic treatment following excision (e.g. valvular heart disease).

Study & Design

• Study Type: Interventional
• Study Design: Not specified